HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical experience with chemoradiotherapy comprising S-1 plus low-dose cisplatin in a patient with stage IV anal cancer.

Abstract
We report a case of anal cancer in a 58-year-old woman who complained of narrow, bloody stools and anal pain. Physical examination revealed anal stenosis associated with a circular mass arising in the anal canal. Histological examination of biopsy specimens confirmed a diagnosis of moderately differentiated squamous cell carcinoma. Enhanced computed tomography revealed anal cancer invading the levator ani and the vagina, with lymph-node, multiple hepatic, and pulmonary metastases. The patient received two cycle of chemoradiotherapy with S-1 plus low-dose cisplatin with rest for 4 weeks, leading to complete response of the primary lesion and a partial response of the metastatic lesions. Each cycle included oral S-1 (120 mg/body; day 1-21), cisplatin (10 mg/body; day 1-5, 8-12) and radiotherapy (2 Gy/day; day 1-5, 8-12, 15-19). Adverse effects of treatment were mild perineal skin erosion and mild appetite loss, but no hematologic toxicity. Although the patient died 16 months after first admission, chemoradiotherapy with S-1 plus cisplatin is potentially effective for the management of advanced anal cancer.
AuthorsNobuhiro Nitori, Yutaro Kato, Ayu Kato, Tomoaki Deguchi, Akihiro Okada, Masayuki Kojima, Junko Kuroda, Tomohisa Kadomura, Keisuke Kubota, Nobuto Origuchi, Masato Fujisaki, Masaki Kitajima
JournalAnticancer research (Anticancer Res) Vol. 31 Issue 11 Pg. 3983-9 (Nov 2011) ISSN: 1791-7530 [Electronic] Greece
PMID22110231 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Cisplatin
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Anus Neoplasms (pathology, therapy)
  • Chemoradiotherapy
  • Cisplatin (administration & dosage)
  • Drug Combinations
  • Female
  • Gamma Rays
  • Humans
  • Liver Neoplasms (secondary, therapy)
  • Lung Neoplasms (secondary, therapy)
  • Lymphatic Metastasis
  • Middle Aged
  • Neoplasm Staging
  • Oxonic Acid (administration & dosage)
  • Tegafur (administration & dosage)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: